Health
Analysts predicted new obesity medicines would be blockbusters. Now they’re raising their forecasts
As new weight loss medications garnered buzz last year, analysts’ forecasts signaled these drugs would be blockbusters, with some of the highest estimates calling for peak sales of at least $100 billion. In recent days, the expectations are moving higher still. The initial projections were made before Wall Street saw the results of Novo Nordisk’s […]
Read More
Covid, RSV and flu vaccines are now available — here’s how to decide whether to get them together
Pharmacist Ani Martirosyan administers an immunization to a patient at a CVS on Tuesday, Sept. 12, 2023 in Glendale, CA. Brian Van Der Brug | Los Angeles Times | Getty Images For the first time ever, vaccines for Covid, the flu and respiratory syncytial virus are available in the U.S. Public health officials are urging […]
Read More
More than 60,000 Kaiser Permanente workers vote to authorize strike
Kaiser Permanente mental health workers and supporters march outside a Kaiser facility in Sacramento, Calif., Monday, Aug. 15, 2022. Rich Pedroncelli | AP More than 60,000 health care workers on Thursday voted to authorize a strike against Kaiser Permanente if an agreement is not reached when their current contract expires on Sept. 30. Members of […]
Read More
Planned Parenthood will resume abortions in Wisconsin after court rules against 1849 ban
In this photo is the Madison South Health Center that is owned and operated by Planned Parenthood of Wisconsin. Kevin Wang | AP Planned Parenthood will resume abortions in Wisconsin next week, after a state court ruled that a 174-year-old criminal law does not ban the procedure. Abortion services will resume on Monday at Planned […]
Read More
New York expands legal marijuana licenses — but some would-be retailers feel left behind
A woman walks by a smoke shop in New York City that displays a marijuana leaf in the window, June 16, 2023. Spencer Platt | Getty Images News | Getty Images Coss Marte’s marijuana dispensary in lower Manhattan has already cost him over $1 million, and it’s not even open yet. He was awarded a […]
Read More
New Covid vaccines could reach Americans as soon as Thursday – here’s what you need to know
A nurse prepares doses of the Pfizer vaccine during a COVID-19 vaccination event at Josephine’s Southern Cooking in Chatham, Illinois, Dec. 30, 2021. Brian Cassella | Tribune News Service | Getty Images A new round of Covid vaccines is finally here in the U.S. The Centers for Disease Control and Prevention cleared single-strain shots from […]
Read More
Decongestant found in many cold, allergy medicines doesn’t actually work, FDA advisors say
A combination package of Procter & Gamble Co. DayQuil Severe and NyQuil Severe brand cold and flu medicine is arranged for a photograph in Tiskilwa, Illinois. Daniel Acker | Bloomberg | Getty Images The main ingredient used in many popular over-the-counter cold and allergy medications doesn’t actually work to get rid of nasal congestion, an […]
Read More
Ozempic, Wegovy may curb drinking, smoking and other addictive behaviors – here’s what we know
An Ozempic (semaglutide) injection pen is seen on a kitchen table in Riga, Latvia on 06 August, 2023. Jaap Arriens | Nurphoto | Getty Images Heather Le Biller shed 9 pounds within the first week of taking Novo Nordisk‘s blockbuster diabetes drug Ozempic – and then even more as she continued treatment. Le Biller, a […]
Read More
Big pharma’s blockbuster obesity drug battle is just getting started, and it’s headed for $100 billion
Ozempic drug to treat diabetes. Courtesy: Ozempic In their most recent earnings reports, Novo Nordisk and Eli Lilly proved why they are the undisputed heavyweights in the prizefight for control of the rapidly growing weight-loss medications market. Beyond staggering sales figures for Novo’s Ozempic and Wegovy and Lilly’s Mounjaro, news of a study showing Wegovy […]
Read More
Obesity drugs’ popularity put a dent in these stocks. Why analysts say they’re still worth buying
Industry analysts are insisting that new weight loss and diabetes drugs like Ozempic won’t hurt the demand for insulin pumps and continuous glucose monitors, but most investors aren’t buying it. Medical device stocks have been falling session after session, prompting UBS analyst Danielle Antalffy on Wednesday to lower her price targets for Dexcom and a […]
Read More